The Harbor Health Care UCITS ETF (WELL) allows investors to access the sustained expansion and cutting-edge innovations of the U.S. healthcare system. This actively managed fund, overseen by the skilled team at Westfield Capital Management, aims to surpass the performance of the wider healthcare sector. It achieves this by focusing investments on high-caliber companies known for their distinct products, technologies, and services, ensuring they meet strict valuation standards. The strategy specifically embraces transformative themes such as targeted oncology, liquid biopsy, gene therapy, and orphan diseases, which are identified as significant drivers of long-term growth.